Carisoprodol

Pain management compliance programs, forensic toxicology investigations, clinical toxicology screening, and driving under the influence cases require monitoring of carisoprodol, a centrally acting skeletal muscle relaxant and Schedule IV controlled substance commonly prescribed for acute musculoskeletal pain. Quality control materials from UTAK contain carisoprodol within our miscellaneous and SAMHSA confirmation panels, available in urine and oral fluid matrices at multiple concentration levels for both immunoassay screening and GC-MS or LC-MS/MS confirmatory methods. Stock and custom QC solutions can incorporate the primary active metabolite meprobamate along with other commonly monitored analytes such as benzodiazepines, opioids, benzoylecgonine, phencyclidine, and zolpidem to support comprehensive pain management, drugs of abuse, and forensic toxicology QC programs.